tirzepatide help with depression why does cause High-dose can mute the brain's pleasure circuitry, turning life's rewards New weight-loss drugs linked to

It says patients with type 2 diabetes may benefit more from tirzepatide's dual mechanism, which activates both GLP-1 and GIP receptors and enhances insulin secretion alongside appetite suppression

Tirzepatide alone produces significant weight lossclinical trials show average reductions of 20-22% body weight over 68 weeksmaking additional lipotropic support potentially unnecessary for many patients

In 2021 - 2022, a stronger dose, weekly injectable formulation of Semaglutide (brand name Wegovy) was approved by the US FDA as a medication for weight loss in patients with at least one weight related medical issue

For the first time, we have a drug, semaglutide, that not only causes weight loss, but also reduces the formation of atherosclerotic plaque and prevents deaths and cardiovascular events, says Paola Harwicz, a cardiologist and obesity specialist in Buenos Aires who headed the Cardiometabolism Council of the Argentine Society of Cardiology and participated in the meeting in Philadelphia